Supplementary Table 2 from Using Pharmacokinetic and Pharmacodynamic Data in Early Decision Making Regarding Drug Development: A Phase I Clinical Trial Evaluating Tyrosine Kinase Inhibitor, AEE788
| Autor: | Chris H. Takimoto, Erika Martinelli, Allan van Oosterom, Eric Walk, Kathryn Parker, Margaret Dugan, Jerry Huang, Christie Low, William Mietlowski, Clifford DiLea, Josep Tabernero, Frederico Rojo, Herlinde Dumez, Patrick Schöffski, Alain C. Mita, José Baselga |
|---|---|
| Rok vydání: | 2023 |
| Popis: | PDF file - 72K, Most Frequent Adverse Events (≥ 15%, any dose group) by Initial Dose Group (Safety Population) |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|